SPAGGIARI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.625
AS - Asia 1.541
EU - Europa 1.121
SA - Sud America 242
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 12
Totale 4.617
Nazione #
US - Stati Uniti d'America 1.549
IT - Italia 639
CN - Cina 435
SG - Singapore 427
VN - Vietnam 159
BR - Brasile 158
HK - Hong Kong 157
GB - Regno Unito 82
DE - Germania 76
BD - Bangladesh 69
KR - Corea 64
IN - India 60
RU - Federazione Russa 58
SE - Svezia 45
FI - Finlandia 39
MX - Messico 35
AR - Argentina 33
ID - Indonesia 33
FR - Francia 27
CA - Canada 26
NL - Olanda 23
EC - Ecuador 22
HU - Ungheria 20
IQ - Iraq 20
AT - Austria 17
TR - Turchia 15
JP - Giappone 14
MY - Malesia 14
PL - Polonia 14
PK - Pakistan 13
AU - Australia 11
PT - Portogallo 11
ZA - Sudafrica 11
CO - Colombia 10
ES - Italia 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
MA - Marocco 8
UA - Ucraina 8
UZ - Uzbekistan 8
BG - Bulgaria 7
CL - Cile 7
CZ - Repubblica Ceca 7
EG - Egitto 7
NP - Nepal 7
TH - Thailandia 7
BE - Belgio 6
CR - Costa Rica 5
IL - Israele 5
PH - Filippine 5
PY - Paraguay 5
DZ - Algeria 4
GR - Grecia 4
MT - Malta 4
RO - Romania 4
VE - Venezuela 4
CH - Svizzera 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
IR - Iran 3
JM - Giamaica 3
JO - Giordania 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
GT - Guatemala 2
IE - Irlanda 2
LK - Sri Lanka 2
PE - Perù 2
TT - Trinidad e Tobago 2
BJ - Benin 1
CD - Congo 1
CG - Congo 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UG - Uganda 1
Totale 4.584
Città #
Singapore 287
Santa Clara 212
Ashburn 203
Hefei 195
San Jose 181
Hong Kong 136
Council Bluffs 128
Modena 88
Seoul 62
Bologna 61
New York 59
Beijing 57
Ho Chi Minh City 56
Los Angeles 56
Dallas 53
Carpi 51
London 38
Hanoi 35
Milan 32
Reggio Emilia 32
Chandler 30
Jakarta 26
Chicago 23
Rome 22
Parma 21
Helsinki 18
São Paulo 18
The Dalles 18
Buffalo 17
Munich 17
Nyköping 17
Haiphong 16
Mexico City 16
Nuremberg 16
Orem 15
Szeged 15
Chennai 14
Trieste 14
Kent 13
Lauterbourg 13
Moscow 13
Tokyo 13
Lappeenranta 12
Poplar 11
Warsaw 11
Atlanta 10
Boardman 10
Central 10
Montreal 10
Baghdad 9
Brooklyn 9
Denver 9
Frankfurt am Main 9
Guangzhou 9
Houston 9
Naples 9
Roteglia 9
Stockholm 9
Tiruchirappalli 9
Turku 9
Amsterdam 8
Boston 8
Guayaquil 8
Johannesburg 8
Mumbai 8
Perugia 8
Vienna 8
Florence 7
Islamabad 7
Miami 7
Quito 7
San Francisco 7
Somerville 7
Tashkent 7
Ankara 6
Bangkok 6
Da Nang 6
Garner 6
Kuala Lumpur 6
Memphis 6
Padova 6
Piscataway 6
Sai Kung 6
Seattle 6
Bogotá 5
Buenos Aires 5
Casablanca 5
Erbil 5
Falkenstein 5
Fidenza 5
Honolulu 5
Manchester 5
San José 5
San Martino in Rio 5
Shanghai 5
Torreano 5
Abu Dhabi 4
Baltimore 4
Bremen 4
Cairo 4
Totale 2.821
Nome #
Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro 375
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 355
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro 355
In vitro analysis of epithelial tolerability and anti-Candida effect of a new lactic acid-based vaginal gel formulation 325
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 322
Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis 280
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 253
An Untargeted Metabolomic Analysis of Lacticaseibacillus (L.) rhamnosus, Lactobacillus (L.) acidophilus, Lactiplantibacillus (L.) plantarum and Limosilactobacillus (L.) reuteri Reveals an Upregulated Production of Inosine from L. rhamnosus 240
THE PROTECTIVE ROLE OF TYPE-I INTERFERONS AXIS ACTIVATION IN THE VULVOVAGINAL CANDIDIASIS MODEL 227
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro 213
Candidalysin is a key player in activating vaginal cell ROS in an in vitro infection model 199
Cell-Free Supernatant from a Strain of Bacillus siamensis Isolated from the Skin Showed a Broad Spectrum of Antimicrobial Activity 189
In vivo colonization and pathogenic potential of C. africana 184
The pathogenic and colonization potential of Candida africana 183
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 180
Biological Features, Antimicrobial Susceptibility and Phenotypic Characterization of Candidozyma auris CDC B11903 Grown at Different Temperatures 162
The protective role of type I interferon pathway activation in an in vitro model of vulvovaginal candidiasis 155
The Community State Type I dominated by Lactobacillus crispatus is the most effective vaginal microbiota in counteracting Candida albicans infection in vitro 106
Differential modulation of complosome by colonizing and VVC-associated Candida (C.) albicans strains in vaginal epithelial cells 89
Vaginal clinical isolates of Candida albicans differentially modulate type I interferon pathway in an in vitro infection model 88
Untargeted Metabolomic Analysis of Cell-Free Supernatants (CFSs) from Different Clinical Isolates of Saccharomyces cerevisiae and Their Effects on Candida albicans Virulence 42
Prophylactic Potential of Heyndrickxia coagulans Strain LMG S-24828 in an In Vitro Model of ESBL–Escherichia coli Urothelial Infection 42
Is immunotherapy safe and effective in patients with VEXAS syndrome? 36
Differential Virulence of Vaginal Candida albicans IsolatesC orrelates with Host Inflammatory Responses in VVC/RVVC 17
Totale 4.617
Categoria #
all - tutte 14.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022101 0 0 9 20 5 5 5 2 7 0 27 21
2022/2023333 6 11 21 20 31 53 19 45 46 26 30 25
2023/2024373 14 16 36 26 42 47 37 17 27 43 32 36
2024/20251.043 15 25 30 76 166 152 76 76 95 73 98 161
2025/20262.391 154 139 164 369 346 160 242 125 199 249 163 81
2026/2027376 95 176 105 0 0 0 0 0 0 0 0 0
Totale 4.617